1. 6'-amidino-2-naphthyl 4-guanidinobenzoate
2. 6'-amidino-2-naphthyl 4-guanidinobenzoate, Dimethanesulfonate
3. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester
4. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dihydrochloride
5. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dimethanesulfonate
6. Ckd-314
7. Ckd314
8. Fut 175
9. Fut-175
10. Nafamostat
11. Nafamostat Dihydrochloride
12. Nafamostat Mesilate
13. Nafamstat Mesilate
14. Ronastat
1. 82956-11-4
2. Nafamostat Mesilate
3. Fut-175
4. Nafamstat Mesilate
5. Ronastat
6. Nafamostat Mesylate [usan]
7. Ronastat (tn)
8. Nafamostat Dimethanesulfonate
9. Nafamostat Mesylate (usan)
10. Nafamostat Mesilate (jp17)
11. Fut 175
12. Benzoic Acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dimethanesulfonate
13. Dtxsid7046128
14. Nafamostat Mesilate [jan]
15. Nafamostat Mesilate [mart.]
16. Nafamostat Mesilate [who-dd]
17. 1d2t74921w
18. Unii-1d2t74921w
19. 6-amidino-2-naphthyl P-guanidinobenzoate, Dimethanesulfonate
20. Ckd-314
21. Nafamostat Dimethanesulfonate [mi]
22. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dimethanesulfonate
23. 6-amidino-2-naphthyl 4-guanidinobenzoate Dimethanesulfonate
24. Nafamostat Mesilate (mart.)
25. 6-amidino-2-naphthyl P-guanidinobenzoate, Dimethanesulphonate
26. Dtxcid5026128
27. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dimethanesulphonate
28. Fut175
29. 6'-amidino-2-naphthyl 4-guanidinobenzoate, Dimethanesulfonate
30. 6-amidinonaphthalen-2-yl 4-guanidinobenzoate Bis(methanesulfonate)
31. Futhan
32. Nafamostat (mesylate)
33. Nafamstat
34. 6-carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate Dimethanesulfonate
35. 6-[amino(imino)methyl]-2-naphthyl 4-{[amino(imino)methyl]amino}benzoate Dimethanesulfonate
36. (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate;methanesulfonic Acid
37. Mfcd00941430
38. Nafamostat (mesylate)?
39. Schembl1568755
40. Chembl3989553
41. Hy-b0190a
42. Hms3654j21
43. 6-amidino-2-naphthyl 4-guanidinobenzoate Bis(methanesulfonate)
44. Bcp04841
45. Ac-984
46. S1386
47. 4-guanidinobenzoic Acid 6-amidino-2-naphthyl Ester Bis(methanesulfonate)
48. Akos015852498
49. Nafamostat Mesylate, >=98% (hplc)
50. Ccg-207877
51. Fa26119
52. Hs-0059
53. Nafamostat Mesylate - Bio-x Trade Mark
54. Ba164628
55. N0959
56. Sw219392-1
57. D01670
58. F52835
59. Sbi-0207120.0001
60. Q27252259
61. Fut-175;6-amidino-2-naphthyl P-guanidinobenzoate Dimethanesulfonate
62. Fut-175, 6-amidino-2-naphthyl-4-guanidinoenzoate, Mesylate;6-amidino-2-naphthyl 4-guanidino-benzoate Dimethanesulphonate
Molecular Weight | 539.6 g/mol |
---|---|
Molecular Formula | C21H25N5O8S2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 266 |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 645 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Complement Inactivating Agents
Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. (See all compounds classified as Complement Inactivating Agents.)
Trypsin Inhibitors
Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Serine Proteinase Inhibitors
Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)